Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Enova International | ENVA | Oct 11, 2024 | 85.98 | +2.25 |
Enovis | ENOV | Oct 11, 2024 | 40.22 | +3.87 |
Enovix | ENVX | Oct 11, 2024 | 12.79 | +9.36 |
Enphase Energy | ENPH | Oct 11, 2024 | 100.97 | +1.79 |
Enphys Acquisition | NFYS | Oct 11, 2024 | 10.99 | 0.00 |
Enpro | NPO | Oct 11, 2024 | 161.67 | +2.32 |
Enservco | ENSV | Oct 11, 2024 | 0.15 | -1.33 |
Enstar Group | ESGR | Oct 11, 2024 | 323.35 | +0.58 |
Enstar Group Depository E Pref | ESGRO | Oct 11, 2024 | 20.73 | +0.60 |
Enstar Pref | ESGRP | Oct 11, 2024 | 20.18 | +0.65 |
Ensysce Biosciences | ENSC | Oct 11, 2024 | 0.18 | -4.41 |
Entegris | ENTG | Oct 11, 2024 | 108.90 | +0.77 |
Entera Bio | ENTX | Oct 11, 2024 | 1.86 | +4.49 |
Entergy | ETR | Oct 11, 2024 | 130.64 | +1.22 |
Entergy Texas A Pref | ETI- | Oct 11, 2024 | 24.75 | +0.61 |
Entergy Utility Enterprises | EMP | Oct 11, 2024 | 23.15 | +0.43 |
Entero Therapeutics | ENTO | Oct 11, 2024 | 0.47 | +17.41 |
Enterprise Bancorp | EBTC | Oct 11, 2024 | 32.32 | +3.46 |
Enterprise Financial Services | EFSC | Oct 11, 2024 | 50.67 | +2.59 |
Enterprise Financial Services A Pref | EFSCP | Oct 11, 2024 | 21.25 | +1.63 |
Enterprise Products Partners LP Unit | EPD | Oct 11, 2024 | 29.45 | +0.68 |
Entrada Therapeutics | TRDA | Oct 11, 2024 | 16.78 | +6.14 |
Entravision Communications | EVC | Oct 11, 2024 | 2.13 | +3.40 |
Envela | ELA | Oct 11, 2024 | 5.34 | 0.00 |
Enveric Biosciences | ENVB | Oct 11, 2024 | 0.42 | -3.78 |
Envestnet | ENV | Oct 11, 2024 | 62.67 | +0.05 |
Enviri | NVRI | Oct 11, 2024 | 10.59 | +3.72 |
Environmental Svcs ETF Market Vectors | EVX | Oct 11, 2024 | 181.35 | +1.11 |
Envirotech Vehicles | EVTV | Oct 11, 2024 | 1.74 | -0.57 |
Envista | NVST | Oct 11, 2024 | 18.13 | +1.17 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.